--- title: "July 2026's Top Stocks Believed To Be Trading Below Intrinsic Value" type: "News" locale: "en" url: "https://longbridge.com/en/news/294198218.md" description: "Amidst a US market decline, Simply Wall St identifies top stocks trading below intrinsic value based on cash flows. Key undervalued picks include VSE, Tutor Perini, and Reddit, with discounts up to 49%. Detailed analysis highlights AbbVie (43.4% discount), Guidewire Software (23.7%), and Unity Software (46.7%) as potential opportunities despite varying financial challenges and growth forecasts." datetime: "2026-07-29T11:15:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294198218.md) - [en](https://longbridge.com/en/news/294198218.md) - [zh-HK](https://longbridge.com/zh-HK/news/294198218.md) --- # July 2026's Top Stocks Believed To Be Trading Below Intrinsic Value Over the last 7 days, the United States market has experienced a 1.5% decline, although it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying stocks that are believed to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst broader market growth trends. ### Top 10 Undervalued Stocks Based On Cash Flows In The United States **Name** **Current Price** **Fair Value (Est)** **Discount (Est)** VSE (VSEC) $199.33 $386.21 48.4% Tutor Perini (TPC) $81.98 $162.49 49.5% Reddit (RDDT) $178.44 $354.12 49.6% Rayonier (RYN) $22.09 $42.93 48.5% Neutron Holdings (LIME) $26.89 $52.45 48.7% Mobileye Global (MBLY) $8.43 $16.44 48.7% Goosehead Insurance (GSHD) $68.82 $134.00 48.6% FatPipe (FATN) $5.10 $9.99 48.9% Dime Commercial Bancshares (DCOM) $40.81 $79.24 48.5% Beacon Financial (BBT) $29.95 $59.31 49.5% Click here to see the full list of 154 stocks from our Undervalued US Stocks Based On Cash Flows screener. We're going to check out a few of the best picks from our screener tool. ## AbbVie (ABBV) **Overview:** AbbVie Inc. is a research-based biopharmaceutical company involved in the development, manufacturing, and sale of medicines globally, with a market cap of approximately $453.91 billion. **Operations:** The company generates revenue of $62.82 billion from its Innovative Medicines and Therapies segment. **Estimated Discount To Fair Value:** 43.4% AbbVie is trading significantly below its estimated future cash flow value, suggesting it may be undervalued. However, despite high debt levels and a dividend not fully covered by earnings, AbbVie's earnings are forecast to grow substantially faster than the US market. Recent European approval of RINVOQ for non-segmental vitiligo could bolster revenues. While revenue growth lags behind the market, AbbVie's strong cash flow valuation and positive product developments highlight potential investment appeal amidst financial challenges. - Our comprehensive growth report raises the possibility that AbbVie is poised for substantial financial growth. - Delve into the full analysis health report here for a deeper understanding of AbbVie. ABBV Discounted Cash Flow as at Jul 2026 ## Guidewire Software (GWRE) **Overview:** Guidewire Software, Inc. offers a platform for property and casualty insurers globally and has a market cap of approximately $12.43 billion. **Operations:** The company generates revenue primarily from its Software & Programming segment, amounting to $1.42 billion. **Estimated Discount To Fair Value:** 23.7% Guidewire Software is trading over 20% below its estimated future cash flow value, highlighting potential undervaluation. The company recently raised its earnings guidance for fiscal year 2026, projecting revenue between US$1.46 billion and US$1.47 billion and operating income up to US$134 million, driven by strong third-quarter results. Despite insider selling and a decline in quarterly net income compared to the previous year, Guidewire's earnings are expected to grow significantly faster than the market over the next three years. - In light of our recent growth report, it seems possible that Guidewire Software's financial performance will exceed current levels. - Navigate through the intricacies of Guidewire Software with our comprehensive financial health report here. GWRE Discounted Cash Flow as at Jul 2026 ## Unity Software (U) **Overview:** Unity Software Inc. provides a platform for creating and expanding games and interactive experiences across various devices globally, with a market cap of approximately $13.29 billion. **Operations:** The company's revenue primarily comes from its Software Solutions segment, which generated $1.92 billion. **Estimated Discount To Fair Value:** 46.7% Unity Software is trading 46.7% below its estimated future cash flow value of US$59.69, suggesting potential undervaluation. Despite a significant net loss of US$347.61 million in Q1 2026, Unity's earnings are forecast to grow rapidly at 76.36% annually, with profitability expected within three years. However, recent insider selling and removal from several growth benchmarks may raise concerns among investors about the company's short-term prospects and market positioning. - Our earnings growth report unveils the potential for significant increases in Unity Software's future results. - Click here to discover the nuances of Unity Software with our detailed financial health report. U Discounted Cash Flow as at Jul 2026 ## Key Takeaways - Take a closer look at our Undervalued US Stocks Based On Cash Flows list of 154 companies by clicking here. - Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. - Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. ## Interested In Other Possibilities? - Explore high-performing small cap companies that haven't yet garnered significant analyst attention. - Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. - Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.** We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [GWRE.US](https://longbridge.com/en/quote/GWRE.US.md) - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) - [RDDT.US](https://longbridge.com/en/quote/RDDT.US.md) - [TPC.US](https://longbridge.com/en/quote/TPC.US.md) - [VSEC.US](https://longbridge.com/en/quote/VSEC.US.md) - [U.US](https://longbridge.com/en/quote/U.US.md) - [RDTL.US](https://longbridge.com/en/quote/RDTL.US.md) - [UNX.US](https://longbridge.com/en/quote/UNX.US.md) - [RDYY.US](https://longbridge.com/en/quote/RDYY.US.md) - [RYN.US](https://longbridge.com/en/quote/RYN.US.md) - [MBLY.US](https://longbridge.com/en/quote/MBLY.US.md) - [GSHD.US](https://longbridge.com/en/quote/GSHD.US.md) - [DCOM.US](https://longbridge.com/en/quote/DCOM.US.md) - [BBT.US](https://longbridge.com/en/quote/BBT.US.md) - [VSECU.US](https://longbridge.com/en/quote/VSECU.US.md) - [DCOMG.US](https://longbridge.com/en/quote/DCOMG.US.md) - [DCOMP.US](https://longbridge.com/en/quote/DCOMP.US.md) ## Related News & Research - [AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full Analysis](https://longbridge.com/en/news/294086753.md) - [The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo](https://longbridge.com/en/news/294200563.md) - [Guidewire CEO Michael Rosenbaum disposes of 1,200 shares for $170,772](https://longbridge.com/en/news/293977498.md) - [AbbVie publishes pipeline presentation highlighting July 2026 R&D program updates](https://longbridge.com/en/news/294528502.md) - [Is Guidewire (GWRE) Quietly Reframing Its Cloud‑and‑AI Story With New Board and ProNavigator Moves?](https://longbridge.com/en/news/293862480.md)